305 related articles for article (PubMed ID: 17694388)
1. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
Gannon RL; Millan MJ
Psychopharmacology (Berl); 2007 Dec; 195(3):325-32. PubMed ID: 17694388
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
[TBL] [Abstract][Full Text] [Related]
3. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Hallbäck I; Hägg S; Eriksson AC; Whiss PA
Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
6. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
Gannon RL
Neuroscience; 2003; 119(2):567-76. PubMed ID: 12770569
[TBL] [Abstract][Full Text] [Related]
8. Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.
Weber M; Talmon S; Schulze I; Boeddinghaus C; Gross G; Schoemaker H; Wicke KM
Psychopharmacology (Berl); 2009 May; 203(4):753-62. PubMed ID: 19104776
[TBL] [Abstract][Full Text] [Related]
9. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
11. Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.
Gannon RL; Peglion JL; Millan MJ
Eur Neuropsychopharmacol; 2009 Dec; 19(12):887-97. PubMed ID: 19604677
[TBL] [Abstract][Full Text] [Related]
12. Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats.
Gray VC; Hughes RN
Behav Brain Res; 2015 Mar; 281():43-54. PubMed ID: 25523028
[TBL] [Abstract][Full Text] [Related]
13. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
Takahashi E; Katayama M; Niimi K; Itakura C
Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of antidepressant agents: a review.
Dekeyne A; Millan MJ
Behav Pharmacol; 2003 Sep; 14(5-6):391-407. PubMed ID: 14501253
[TBL] [Abstract][Full Text] [Related]
15. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
[TBL] [Abstract][Full Text] [Related]
16. Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
Humpston CS; Wood CM; Robinson ES
J Psychopharmacol; 2013 Feb; 27(2):213-21. PubMed ID: 23135241
[TBL] [Abstract][Full Text] [Related]
17. alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Massé F; Hascoët M; Bourin M
Behav Brain Res; 2005 Oct; 164(1):17-28. PubMed ID: 16081166
[TBL] [Abstract][Full Text] [Related]
18. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
[TBL] [Abstract][Full Text] [Related]
20. Serotonin1A-mediated amplification of light-induced phase advances of circadian rhythms in the Syrian hamster: post-light effects.
Lungwitz E; Gannon RL
Brain Res; 2009 Jan; 1250():157-63. PubMed ID: 19041294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
